FdaApplication
ANDA 206916
Identifiers
- fda_app_no: ANDA206916
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | ANDA |
| approval_date | 2021-11-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PALONOSETRON HYDROCHLORIDE | PALONOSETRON HYDROCHLORIDE | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) | INJECTABLE;INTRAVENOUS |
1 product